Segment & Geographic Data Quant-Grade Normalized (live API) API & CSV Delivery

Zymergen's Business Segments

Zymergen's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.

Segment Data As of FY
Reportable Segments
-
Per the company's own filing, this quarter
Largest Segment
-
Total Revenue
$ 3
Consolidated, this quarter
Regions Reported
2
Geographic regions, this quarter
API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/ZY/segments
https://api.csimarket.com/api/v1/companies/ZY/geographic
https://api.csimarket.com/api/v1/companies/ZY/exposure
Programmatic access for models, analytics, and integration workflows.
Dataset & schema
https://api.csimarket.com/api/datasets/business_segments
https://api.csimarket.com/api/schema/business_segments
https://api.csimarket.com/api/meta/business_segments

Zymergen does not report a distinct business-segment axis in its filings - its disaggregated revenue is disclosed by product and service category instead. See the Product & Service breakdown below.

Revenue Share by Region - FY

26%largest
  • Asia26.3%
  • Europe0.2%

Revenue by Geographic Region - FY

RegionPeriodRevenue
(Millions)
% of Total
AsiaFY$ 126.3%
EuropeFY$ 00.2%

Revenue by Product & Service Category - FY

45%largest
  • Revenues from Research and Development Service Agreements45.2%
  • Revenue from Collaborative Arrangement and Other28.3%
  • Automation Revenue18.2%
  • Grant8.2%
  • Research and Development Revenue, Performance Bonuses0%
  • Research and Development Service Revenue, Customer Acceptance Clauses0%

Revenue by Product & Service Category - FY

CategoryPeriodRevenue
(Millions)
% of Total
Revenues from Research and Development Service AgreementsFY$ 145.2%
Revenue from Collaborative Arrangement and OtherFY$ 128.3%
Automation RevenueFY$ 018.2%

Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.

3 more categories available

Sign in to unlock the full Zymergen dataset.

Description of Zymergen

Zymergen Inc. is a leading synthetic biology company that specializes in developing molecules and materials through a combination of automation, machine learning, and genetic engineering. The company was founded in 2013 by Josh Hoffman and Zach Serber and is headquartered in Emeryville, California.

Zymergen's main focus is on utilizing advanced technologies to engineer and optimize microbes for various industrial applications. It aims to provide sustainable solutions to global challenges by designing microbial strains that can produce high-value chemicals, materials, and ingredients more efficiently and sustainably compared to traditional methods.

One of Zymergen's core strengths lies in its immense library of microbial strains, which are carefully selected and modified to carry out specific tasks. These strains are genetically engineered to produce novel compounds or enhance the production efficiency of existing compounds. The company's proprietary automated pipeline for genomic engineering, called Atlas, facilitates the high-throughput genetic screening and modification process.

To achieve its goals, Zymergen employs a multidisciplinary approach combining biology, automation, data analytics, and machine learning. The company leverages extensive datasets to model and predict the behavior of microbes, enabling it to design precise interventions that optimize their performance. This iterative process allows Zymergen to continuously improve and create strains with enhanced functionalities.

Zymergen's applications span a wide range of industries including agriculture, chemicals, electronics, and consumer goods. In agriculture, the company is working towards developing sustainable crop protection solutions by engineering microbes that can produce natural compounds with pesticidal properties. In the chemicals industry, Zymergen designs and produces specialty chemicals, such as advanced materials and adhesives, using engineered microbes.

The electronics sector benefits from Zymergen's expertise in developing advanced materials with enhanced properties, such as conductive polymers or bio-based materials for flexible electronics. Additionally, the company is involved in creating new ingredients for the consumer goods industry, such as specialty proteins and other natural substances that can be used as alternatives to traditional ingredients.

Zymergen has established collaborations and partnerships with numerous companies in various industries to commercialize its innovations. By working closely with these partners, Zymergen aims to accelerate the adoption of its technologies and bring sustainable solutions to market. The company also actively conducts research to expand its portfolio of proprietary strains and applications.

In conclusion, Zymergen Inc. is a trailblazing synthetic biology company that combines automation, machine learning, and genetic engineering to design and optimize microbes for industrial applications. With a focus on sustainability and a multidisciplinary approach, Zymergen aims to transform industries by developing novel materials, chemicals, and ingredients through innovative technologies.
Zymergen Inc. is a biotechnology company that specializes in the development and commercialization of engineered microorganisms and bioprocesses. Their innovative approach leverages synthetic biology to enable the production of diverse products across various industries, including materials, food, agriculture, and pharmaceuticals. Here is a detailed breakdown of the segments, products, and services Zymergen offers:

Segments

1. Materials Science
- Bio-based Polymers: Zymergen focuses on creating sustainable materials that can replace traditional petroleum-based polymers. Their bio-based polymers can be used in packaging, textiles, and industrial applications.
- High-Performance Coatings: The company develops bioengineered coatings that enhance the durability, functionality, and environmental friendliness of various surfaces.

2. Agriculture
- Bioagriculture Solutions: Zymergens engineering of microorganisms aids in the creation of bio-based agricultural products, such as effective biopesticides and fertilizers that reduce the reliance on synthetic chemicals.
- Crop Improvement: The company employs advanced genomics and biology to enhance crop yields and resilience by developing microbial solutions that support plant health.

3. Healthcare and Pharmaceuticals
- Biologics Production: Zymergens technology can be utilized to produce complex biologics, which are crucial for therapeutic applications in medicine.
- Small Molecule Discovery and Production: The company is involved in the rapid discovery and engineering of small molecules that can serve as drug candidates.

4. Food and Nutrition
- Fermentation Technologies: Zymergen applies synthetic biology in fermentation processes to create novel food ingredients and additives that enhance taste, nutrition, and shelf-life.
- Alternative Proteins: They are exploring ways to produce proteins through microbial fermentation, reducing the environmental footprint associated with traditional livestock farming.

Products

1. Bioengineered Materials
- Zymergens Transparent Conductive Films: Innovative films for applications in electronics, allowing for better performance in displays and other electronic devices.
- Eco-friendly Packaging Solutions: Biodegradable and renewable packaging materials that cater to companies seeking sustainable options.

2. Agricultural Products
- Microbial Inoculants: Products that enhance soil health and crop productivity while minimizing chemical use.
- Biopesticides: Targeted microbial solutions designed to combat specific pests without harmful effects on non-target species and ecosystems.

3. Health Products
- Therapeutic Proteins: Bio-manufactured proteins intended for use in advanced therapies, vaccines, or treatments for various diseases.

4. Food Ingredients
- Natural Flavoring Agents: Engineered microbes producing natural flavors and additives that meet consumer demand for cleaner labels.
- Nutritional Supplements: Bioproducts designed for dietary enhancement, including vitamins and enzymes sourced from engineered organisms.

Services

1. Contract Research and Development
- Zymergen offers R&D services to other biotech and pharmaceutical companies, helping them leverage their synthetic biology platform for various applications.
- Collaboration with partners to develop custom strains and bioprocesses tailored to specific needs across industries.

2. Consulting Services
- Providing strategic consulting to businesses looking to transition to sustainable practices through biotechnology, encompassing materials science, agriculture, and health.

3. Licensing Technologies
- Zymergen licenses its proprietary technologies, methodologies, and engineered microbial strains to other companies, enabling them to develop their products efficiently and sustainably.

4. Analytical Services
- Offering extensive analytical capabilities for testing and characterization of biological materials, advising customers on optimizing their processes and products.

In sum, Zymergen Inc. operates within a broad range of segments, spearheading solutions that merge technology with sustainability across multiple industries. The integration of synthetic biology in their products and services demonstrates a commitment to addressing global challenges such as environmental sustainability, food security, and health innovation. Their comprehensive portfolio not only supports traditional industries but also propels them toward a more sustainable future.
Get the full CSIMarket dataset: Subscribe API License